1. Zhang, Zhengdong, Chen, Chun, Guo, Weike, Sun, Zhenghua, Geng, Xiaoping. 2016. DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53. In Medical science monitor : international medical journal of experimental and clinical research, 22, 197-205. doi:. https://pubmed.ncbi.nlm.nih.gov/26784388/
2. Jiang, Liang, Liang, Qi-Lian, Liang, Wei-Ming, Huang, Zhi-Gang, Zhang, Xiang-Ning. 2018. Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells. In OncoTargets and therapy, 11, 6665-6671. doi:10.2147/OTT.S176388. https://pubmed.ncbi.nlm.nih.gov/30349300/
3. Wang, Wenjing, Gilligan, Diana M, Sun, Sijie, Wu, Xiaoping, Reems, Jo-Anna. 2011. Distinct functional effects for dynamin 3 during megakaryocytopoiesis. In Stem cells and development, 20, 2139-51. doi:10.1089/scd.2011.0159. https://pubmed.ncbi.nlm.nih.gov/21671749/
4. Ni, Qingfeng, Zhang, Hai, Shi, Xiaoli, Li, Xiangcheng. . Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with Dynamin3. In Bioengineered, 13, 6208-6221. doi:10.1080/21655979.2022.2037249. https://pubmed.ncbi.nlm.nih.gov/35200104/